logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Atsushi Mizokami

Kanazawa University
H指数:55
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Lowest PSA Level Achieved Before CRPC Predicts Abiraterone Response But Not Enzalutamide Response in Metastatic CRPC

在转移性CRPC中，达到CRPC前达到的最低PSA水平可预测阿比特龙的治疗反应，但不能预测恩扎卢amide的治疗反应

Prostate
IF2.5
2026-09-290
PRE
Kohei Hashimoto; Kouji Izumi; Takashi Shima; Yuki Kato; Koji Mita; Takehiko Okamura; Shogo Inoue; Shuichi Tatarano; Nobumichi Tanaka; Noriyasu Kawai; Manabu Kamiyama; Ippei Chikazawa; Seiji Hoshi; Takashi Fukagai; Kazuyoshi Shigehara; Shizuko Takahara; Atsushi Mizokami
Efficacy and Safety of Enzalutamide and Abiraterone in CRPC Patients With a History of Other Cancers: A Sub-Analysis of the ENABLE Study for PCa

恩扎卢替尼和阿比特龙在既往有其他癌症史的患者中的有效性和安全性：针对PCa的ENABLE研究的亚组分析

INTERNATIONAL JOURNAL OF UROLOGY
IF2.2
2026-05-201
PRE
Hoshi, Seiji; Izumi, Kouji; Meguro, Satoru; Shima, Takashi; Kato, Yuki; Mita, Koji; Okamura, Takehiko; Inoue, Shogo; Tatarano, Shuichi; Tanaka, Nobumichi; Yoshio, Yuko; Kamiyama, Manabu; Chikazawa, Ippei; Kawai, Noriyasu; Hashimoto, Kohei; Fukagai, Takashi; Shigehara, Kazuyoshi; Takahara, Shizuko; Mizokami, Atsushi
Fibroblast-mediated KRAS activation in double-negative prostate cancer

成纤维细胞介导的KRAS激活在双阴性前列腺癌中的作用

Cell Death & Disease
IF9.6
2026-05-020
OAAI
Taiki Kamijima; Kouji Izumi; Kaoru Hiratsuka; Takahiro Inaba; Yoshiki Koketsu; Ryunosuke Nakagawa; Ren Toriumi; Shuhei Aoyama; Hiroshi Kano; Tomoyuki Makino; Renato Naito; Suguru Kadomoto; Hiroaki Iwamoto; Hiroshi Yaegashi; Shohei Kawaguchi; Takahiro Nohara; Kazuyoshi Shigehara; Hiroki Nakata; Yohei Saito; Kyoko Nakagawa-Goto; Wen-Jye Lin; Atsushi Mizokami
High-Dose-Rate Brachytherapy Combined with External Beam Radiotherapy for Newly Defined Very High-Risk and Regional Prostate Cancer: A 17-Year Single-Institution Experience

高剂量率近距离治疗联合外照射放疗治疗新定义的极高危和区域前列腺癌：一项17年单机构经验

Cancers
IF4.4
2026-04-170
OA
Tomoyuki Makino; Takayuki Sakurai; Shigeyuki Takamatsu; Ryunosuke Nakagawa; Taiki Kamijima; Hiroshi Kano; Renato Naito; Hiroaki Iwamoto; Hiroshi Yaegashi; Kazuyoshi Shigehara; Takahiro Nohara; Kouji Izumi; Atsushi Mizokami
Post Hoc Subgroup Analysis of Clinical Outcomes in Patients With High-Risk Metastatic Hormone-Naïve Prostate Cancer: Results From a 3-Year Interim Analysis of the J-ROCK Study

高风险转移性激素未治前列腺癌患者临床结局的事后亚组分析：J-ROCK研究3年中期分析结果

Prostate
IF2.5
2026-01-011
OAAI
Mizokami, Atsushi; Matsumoto, Rikiya; Miyake, Hideaki; Uemura, Hiroji; Uemura, Hirotsugu; Kawakami, Satoru; Nakamura, Kazuyoshi; Shigekatsu Maekawa; Tsuchiya, Hiroaki; Okazaki, Sachie; Adachi, Eri; Yano, Ryo; Tajima, Yohei; Fujimoto, Kiyohide; Matsuyama, Hideyasu
Dynamic Changes in Albumin and Systemic Immune-Inflammation Index as Prognostic Markers in Patients Treated with Cabozantinib After Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma

白蛋白和全身免疫炎症指数的动态变化作为接受免疫检查点抑制剂治疗后使用卡博赞尼治疗转移性肾细胞癌患者的预后标志物

Cancers 2025, Vol. 17, Page 3956
IF4.4
2025-12-110
OAAI
Rikushi Fujimura; Hiroshi Yaegashi; Ryunosuke Nakagawa; Taiki Kamijima; Hiroshi Kano; Tomoyuki Makino; Renato Naito; Suguru Kadomoto; Hiroaki Iwamoto; Kazuyoshi Shigehara; Takahiro Nohara; Kouji Izumi; Atsushi Mizokami
Outcomes of Nivolumab-Plus-Ipilimumab in Metastatic Renal Cell Carcinoma: Second Interim Analysis of the J-ENCORE Study

Nivolumab-Plus-Ipilimumab在转移性肾细胞癌中的疗效：J-ENCORE研究的第二次中期分析

INTERNATIONAL JOURNAL OF UROLOGY
IF2.2
2025-11-010
OAAI
Sazuka, Tomokazu; Tatsugami, Katsunori; Shirotake, Suguru; Hamamoto, Shuzo; Nozawa, Masahiro; Numakura, Kazuyuki; Mizokami, Atsushi; Kondo, Tsunenori; Naito, Sei; Abe, Takashige; Ohba, Kojiro; Kimura, Go; Onodera, Shunta; Yamaguchi, Katsumi; Uemura, Hirotsugu
Real-World Efficacy of Postoperative Adjuvant Nivolumab in High-Risk Urothelial Carcinoma: A Retrospective Comparative Study in an Asian Population

高危尿路上皮癌术后辅助纳武利尤单抗的疗效：一项亚洲人群的回顾性比较研究

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
IF1.6
2025-11-010
PRE
Nakagawa, Ryunosuke; Naito, Renato; Izumi, Kouji; Inaba, Takahiro; Toriumi, Ren; Aoyama, Shuhei; Kamijima, Taiki; Kano, Hiroshi; Makino, Tomoyuki; Kadomoto, Suguru; Iwamoto, Hiroaki; Yaegashi, Hiroshi; Kawaguchi, Shohei; Nohara, Takahiro; Shigehara, Kazuyoshi; Mizokami, Atsushi
Fibroblast-specific palladin drives kidney fibrosis via MRTF–SRF signaling

成纤维细胞特异性的palladin通过MRTF–SRF信号通路驱动肾脏纤维化

The Journal of Pathology
IF5.2
2025-10-240
OAAI
Naoki Yamamoto; Norihiko Sakai; Yuta Yamamura; Daichi Kaikoi; Daiki Hayashi; Takahiro Matsuno; Akihiko Koshino; Keisuke Sako; Keisuke Horikoshi; Takahiro Yuasa; Akira Tamai; Taichiro Minami; Megumi Oshima; Shiori Nakagawa; Shinji Kitajima; Akinori Hara; Miho Shimizu; Jumpei Terakawa; Shin-ichi Horike; Takiko Daikoku; Atsushi Mizokami; Hiroko Ikeda; Moeno Kadoguchi; Hiroshi Arakawa; Sumio Ohtsuki; David Lagares; Takashi Wada; Yasunori Iwata
Seven-Year PSA ≤ 0.2 ng/mL After High-Dose-Rate Brachytherapy Indicates Eligibility for Discontinuing PSA Surveillance in Prostate Cancer

高强度率近距离放射治疗后七年内前列腺特异性抗原(PSA)≤0.2 ng/mL表明符合停止前列腺特异性抗原监测的条件，用于前列腺癌。

Cancers 2025, Vol. 17, Page 3151
IF4.4
2025-09-280
OAAI
Tomoyuki Makino; Takayuki Sakurai; Shigeyuki Takamatsu; Ryunosuke Nakagawa; Taiki Kamijima; Hiroshi Kano; Renato Naito; Hiroaki Iwamoto; Hiroshi Yaegashi; Kazuyoshi Shigehara; Takahiro Nohara; Kouji Izumi; Atsushi Mizokami
Androgen Receptor-Controlled microRNA-124-3p.2 Suppresses Prostate Cancer Progression via CCL2 Inhibition

雄激素受体调控的microRNA-124-3p.2通过抑制CCL2抑制前列腺癌进展。

Cancer Science
IF4.3
2025-07-220
OAAI
Shuhei Aoyama; Kouji Izumi; Kaoru Hiratsuka; Takahiro Inaba; Yoshiki Koketsu; Ryunosuke Nakagawa; Ren Toriumi; Taiki Kamijima; Hiroshi Kano; Tomoyuki Makino; Renato Naito; Suguru Kadomoto; Hiroaki Iwamoto; Hiroshi Yaegashi; Shohei Kawaguchi; Kazuyoshi Shigehara; Takahiro Nohara; Hiroki Nakata; Yohei Saito; Kyoko Nakagawa-Goto; Wen-Jye Lin; Atsushi Mizokami
Tumor-associated macrophages promote bladder cancer metastasis through the CCL20-CCR6 axis

肿瘤相关巨噬细胞通过CCL20-CCR6轴促进膀胱癌转移

NEOPLASIA
IF7.7
2025-02-010
OAAI
Nakagawa, Ryunosuke; Izumi, Kouji; Hiratsuka, Kaoru; Inaba, Takahiro; Koketsu, Yoshiki; Toriumi, Ren; Aoyama, Shuhei; Kamijima, Taiki; Kano, Hiroshi; Makino, Tomoyuki; Naito, Renato; Kadomoto, Suguru; Iwamoto, Hiroaki; Yaegashi, Hiroshi; Kawaguchi, Shohei; Nohara, Takahiro; Shigehara, Kazuyoshi; Nakata, Hiroki; Lin, Wen-Jye; Mizokami, Atsushi
Phase 3 Study of Talazoparib Plus Enzalutamide Versus Placebo Plus Enzalutamide as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer: TALAPRO-2 Japanese Subgroup Analysis

III期研究：talazoparib 联合 enzalutamide 与安慰剂联合 enzalutamide 作为一线治疗转移性去势抵抗性前列腺癌患者的比较：TALAPRO-2 日本亚组分析

CANCER MEDICINE
IF3.1
2024-12-310
OA
Matsubara, Nobuaki; Miyake, Hideaki; Uemura, Hiroji; Mizokami, Atsushi; Kikukawa, Hiroaki; Kosaka, Takeo; Nishimura, Kazuo; Nakamura, Motonobu; Kobayashi, Kazuki; Komaru, Atsushi; Mori, Yuko; Toyoizumi, Shigeyuki; Hori, Natsuki; Umeyama, Yoshiko; Uemura, Hirotsugu

研究方向

暂未获取到该数据
K
Kouji Izumi
H 指数:34论文数:317被引数:5,725
K
Kazuyoshi Shigehara
H 指数:28论文数:225被引数:2,834
H
Hiroaki Iwamoto
H 指数:28论文数:179被引数:2,614
Y
Yoshifumi Kadono
H 指数:28论文数:212被引数:2,557
H
Hiroshi Yaegashi
H 指数:25论文数:227被引数:2,784
T
Takahiro Nohara
H 指数:19论文数:161被引数:1,614
M
Mikio Namiki
H 指数:0论文数:1被引数:8
E
Evan T. Keller
H 指数:86论文数:546被引数:3.4万
S
Shohei Kawaguchi
H 指数:16论文数:130被引数:1,022
T
Tomoyuki Makino
H 指数:35论文数:186被引数:6,865